Effect of 2 Different High-Dose Methylprednisolone Treatments on Clinical Outcomes in Severe COVID-19 Patients

• Fatma Eser ,
• Bircan Kayaaslan,
• Ayşe Kaya Kalem ,
• İmran Hasanoğlu ,
• Zeynep Bilgiç,
• Dilek Asiltürk,
• Betül Kaplan ,
• Rahmet Güner

Affiliations

Fatma Eser

Department of Infectious Diseases and Clinical Microbiology, Yıldırım Beyazıt University, Faculty of Medicine, Ankara City Hospital, Ankara, Turkey

Bircan Kayaaslan

Department of Infectious Diseases and Clinical Microbiology, Yıldırım Beyazıt University, Faculty of Medicine, Ankara City Hospital, Ankara, Turkey

Ayşe Kaya Kalem

Department of Infectious Diseases and Clinical Microbiology, Yıldırım Beyazıt University, Faculty of Medicine, Ankara City Hospital, Ankara, Turkey

İmran Hasanoğlu

Department of Infectious Diseases and Clinical Microbiology, Yıldırım Beyazıt University, Faculty of Medicine, Ankara City Hospital, Ankara, Turkey

Zeynep Bilgiç

Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey

Dilek Asiltürk

Department of Infectious Diseases and Clinical Microbiology,Ankara City Hospital, Ankara, Turkey

Betül Kaplan

Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey

Rahmet Güner

Department of Infectious Diseases and Clinical Microbiology, Yıldırım Beyazıt University, Faculty of Medicine, Ankara City Hospital, Ankara, Turkey